Section Arrow
PFSA.NASDAQ
- Profusa Inc
(Financial Status)
Quotes are at least 15-min delayed:2025/10/22 07:15 EDT
Pre Market
Last
 0.3082
+0.0035 (+1.15%)
Bid
0.298
Ask
0.32
High 0.3125 
Low 0.2978 
Volume 36181 
Regular Hours
Last
 0.3047
-0.0172 (-5.34%)
Day High 
0.3223 
Prev. Close
0.3219 
1-M High
0.3998 
Volume 
5.07M 
Bid
0.298
Ask
0.32
Day Low
0.3019 
Open
0.3223 
1-M Low
0.281 
Market Cap 
13.44M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.32 
20-SMA 0.32 
50-SMA 0.38 
52-W High 12.76 
52-W Low 0.265 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.53/--
Enterprise Value
13.44M
Balance Sheet
Book Value Per Share
-0.51
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNONTenon Medical Inc1.19-0.09-7.03%0.23PE
Pre Market 1.12 -0.07 -5.88%
QSIQuantum-Si2.34-0.245-9.48%-- 
Pre Market 2.25 -0.09 -3.85%
PACBPacific Biosciences of California1.9-0.08-4.04%-- 
Pre Market 1.91 +0.01 +0.53%
BSXBoston Scientific Corp99.9-0.63-0.63%60.11PE
Pre Market 98.23 -1.67 -1.67%
PFSAProfusa Inc0.3047-0.0172-5.34%-- 
Pre Market 0.3082 +0.0035 +1.15%
Quotes are at least 15-min delayed:2025/10/22 07:15 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and providethe necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.